| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |